The FDA's next chap­ter is of­fi­cial­ly un­der­way.

Pres­i­dent Don­ald Trump an­nounced Hei­di Over­ton as his pick for FDA com­mis­sion­er in a so­cial me­dia post Wednes­day...

Mod­er­na has been say­ing for years that it would di­ver­si­fy its port­fo­lio be­yond in­fec­tious dis­eases. In­vestors were wait­ing for late-stage proof.

On Wednes­day, they got...

Re­gen­eron has se­cured ap­proval for its treat­ment for a de­bil­i­tat­ing dis­ease that re­places mus­cle and con­nec­tive tis­sue with bone.

The FDA on Wednes­day cleared the...

The next gen­er­a­tion of im­munother­a­py ap­pears to have ar­rived.

Mer­ck and Mod­er­na on Wednes­day said their per­son­al­ized can­cer vac­cine, known as in­tismer­an au­to­gene, suc­ceed­ed in...

Af­ter a low­er court re­ject­ed Teva's case last fall, a fed­er­al ap­peals court has re­vived part of the drug­mak­er’s law­suit against Medicare ne­go­ti­a­tions.

The DC...